Mode
Text Size
Log in / Sign up

basal insulin

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of basal insulin

7 trials tracked of basal insulin: 5 in phase 3 or 4 and 4 with published results. The most-cited published study has 285 citations.

7Trials tracked
5Phase 3 & 4
0Recruiting
4With published results
Phase distribution
Phase 3 5 Other / NA 2
  1. Phase 3 GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin Completed · 285 cited
  2. Phase 3 GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA) Completed · 253 cited
  3. Phase 3 A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007). Completed · 189 cited
  4. Phase 3 Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes Completed · 44 cited
  5. Phase 3 Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin Completed
  6. N/A Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes Completed
Show 1 more trials
  1. N/A Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy? Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.